7月15日（周二）13时02分，港股上市公司荣昌生物（09995.HK）股价盘中大涨5.08%，报67.200港元。该股今日成交活跃，成交量达589.438万股，换手率2.83%。
分析人士指出，荣昌生物股价上涨可能与南向资金持续加仓有关。数据显示，南向资金连续4个交易日增持荣昌生物，截至7月14日，港股通共持有荣昌生物10935.24万股，占流通股52.43%。这表明内地投资者对该公司的发展前景持积极态度。
此外，市场对创新药板块的关注度持续提升也可能是推动荣昌生物股价上涨的因素之一。多家机构认为，中国创新药正处于产业红利释放的前夜，具备硬科技实力、能持续创造临床价值的企业将有望穿越周期。作为创新药研发的领先企业之一，荣昌生物或将受益于行业发展趋势。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.